retrospect studi analyz experi mucoepidermoid carcinoma mec salivari gland compar result report literatur total patient treat januari 1983 decemb 2002 depart oral maxillofaci surgeri hanov medic school thirti-three tumor classifi low grade carcinoma tumor high grade carcinoma tumor site parotid gland case sublingu submandibular gland case oral caviti oropharynx case nasal caviti maxillari sinu case t1- t2- t3- t4-tumor n0- n1- n2-neck present resect remain incomplet patient six patient receiv postop radiat overal surviv rate overal local control rate overal region control rate year 79.1 65.5 89.1 80.8 92.3 87.7 none patient develop distant failur grade stage margin statu significantli influenc prognosi mec rare tumor entiti treat specialist centr randomis prospect multicentr trial
salivari epiderm growth factor egf effect oral cancer biologi unknown examin chang minut volum whole rest stimul saliva egf concentr output elisa whole rest stimul saliva befor week surgic treatment oral carcinoma patient compar control group stimul salivari flow increas both control 0.003 patient group--befor 0.007 surgeri 0.005 higher stimul saliva volum level observ befor surgeri post-treatment patient 0.032 trend increas egf salivari concentr tumour excis both rest 0.508 stimul 0.647 saliva similar ascend tendenc egf output stimul saliva post-treatment patient observ 0.878 decreas level egf concentr saliva befor contrari tendenc surgic treatment suggest import role egf oral cancer tumourogenesi
